This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1995 Feb;27(1):364-5.

Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation

M Tanabe¹, S Todo, N Murase, W Irish, H Miyazawa, S Fujisaki, T E Starzl

Affiliations

PMID: 7533411
PMCID: PMC2990219

Comparative Study

Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation

M Tanabe et al. Transplant Proc. 1995 Feb.

. 1995 Feb;27(1):364-5.

Authors

M Tanabe¹, S Todo, N Murase, W Irish, H Miyazawa, S Fujisaki, T E Starzl

Affiliation

¹ Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, PA 15213.

PMID: 7533411
PMCID: PMC2990219

No abstract available

PubMed Disclaimer

Similar articles

Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M, Antoniou E, DeRoover A, Nishimura Y, Howie A, McMaster P. D'Silva M, et al. Transplant Proc. 1996 Apr;28(2):930-1. Transplant Proc. 1996. PMID: 8623467 No abstract available.
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
Zhu Y, Suzuki T, Subbotin VM, Ishizaki N, Jin MB, Urakami A, Shimamura T, Starzl TE, Todo S. Zhu Y, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):308-9. doi: 10.1016/s0041-1345(96)00275-8. Transplant Proc. 1997. PMID: 9123011 Free PMC article. No abstract available.
Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats.
Yoshida S, Toyama Y, Aoki T, Nakamura J, Odaira H, Inagaki Y. Yoshida S, et al. Transplant Proc. 2000 Nov;32(7):2492-3. doi: 10.1016/s0041-1345(00)01762-0. Transplant Proc. 2000. PMID: 11120262 No abstract available.
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J. Lindenfeld J, et al. Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69. Circulation. 2004. PMID: 15611389 Review. No abstract available.
New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA. Hunt SA. Cardiol Rev. 2000 May-Jun;8(3):180-4. Cardiol Rev. 2000. PMID: 11174892 Review.

See all similar articles

Cited by

Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.
Mizumoto C, Kanda J, Ichinohe T, Ishikawa T, Matsui M, Kadowaki N, Kondo T, Imada K, Hishizawa M, Kawabata H, Nishikori M, Yamashita K, Takaori-Kondo A, Hori T, Uchiyama T. Mizumoto C, et al. Int J Hematol. 2009 May;89(4):538-545. doi: 10.1007/s12185-009-0306-5. Epub 2009 Apr 11. Int J Hematol. 2009. PMID: 19363648

References

1. Nelson PH, Eugui E, Wang CC, et al. J Med Chem. 1990;33:833. - PubMed
1. Mizuno K, Tsujino M, Takada M, et al. J Antibiot (Tokyo) 1974;27:775. - PubMed
1. Ono K, Lindsay ES. J Thorac Cardiovasc Surg. 1969;7:225. - PubMed
1. Murase N, Todo S, Lee P-H, et al. Transplant Proc. 1987;19:71. - PMC - PubMed
1. Chou TC. J Theor Biol. 1976;39:253. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information